XML 94 R65.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-based compensation (Details 2) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Additional Stock-based Award Information under Restricted Stock Units Activity      
Stock-based compensation expense, before tax (in dollars) $ 218 $ 283 $ 254
Income tax benefit corresponding to stock-based compensation expense 61 87 79
Unrecognized compensation cost related to nonvested stock-based compensation awards (in dollars) $ 170    
Term of amortization of unrecognized compensation cost over weighted-average remaining requisite service periods (in years) 1 year 7 months    
Cash tax benefits realized from stock awards exercised $ 104 $ 68 $ 253
Tax benefit recordable in APIC on reduction of future income taxes payable $ 15    
Exercise Price Range 22.17 To 57.85      
Exercise Prices Stock Options/SARs outstanding and exercisable      
Exercise Price Range, Minimum (in dollars per share) $ 22.17    
Exercise Price Range, Maximum (in dollars per share) 57.85    
Exercise Price Range 63.04 To 74.77      
Exercise Prices Stock Options/SARs outstanding and exercisable      
Exercise Price Range, Minimum (in dollars per share) 63.04    
Exercise Price Range, Maximum (in dollars per share) 74.77    
Exercise Price Range 83.00 To 86.77      
Exercise Prices Stock Options/SARs outstanding and exercisable      
Exercise Price Range, Minimum (in dollars per share) 83.00    
Exercise Price Range, Maximum (in dollars per share) 86.77    
Exercise Price Range 88.51 To 96.31      
Exercise Prices Stock Options/SARs outstanding and exercisable      
Exercise Price Range, Minimum (in dollars per share) 88.51    
Exercise Price Range, Maximum (in dollars per share) 96.31    
Exercise Price Range 102.13 To 110.09      
Exercise Prices Stock Options/SARs outstanding and exercisable      
Exercise Price Range, Minimum (in dollars per share) 102.13    
Exercise Price Range, Maximum (in dollars per share) $ 110.09    
Stock Options and Stock Appreciation Rights (SARs)      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 32,064,790    
Weighted Average Exercise Price (in dollars per share) $ 82.13    
Aggregate Intrinsic Value outstanding $ 435    
Number of stock awards exercisable at end of the period (in shares) 20,991,816    
Weighted Average Exercise Price (in dollars per share) $ 81.18    
Aggregate Intrinsic Value exercisable $ 325    
Additional Stock-based Award Information under Stock Option and Stock Appreciation Rights      
Weighted-average fair value per share of stock awards granted (in dollars per share) $ 20.64 $ 23.61 $ 29.52
Intrinsic value of stock awards exercised $ 185 $ 93 $ 649
Fair value of stock awards vested 163 155 108
Cash received from stock awards exercised $ 30 $ 59 $ 259
Stock Options and Stock Appreciation Rights (SARs) | Exercise Price Range 22.17 To 57.85      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 5,405,540    
Weighted Average Remaining Contractual Life outstanding (in years) 2 years 9 months 28 days    
Weighted Average Exercise Price (in dollars per share) $ 45.64    
Aggregate Intrinsic Value outstanding $ 255    
Number of stock awards exercisable at end of the period (in shares) 5,405,540    
Weighted-Average Remaining Contractual Life exercisable (in years) 2 years 9 months 28 days    
Weighted Average Exercise Price (in dollars per share) $ 45.64    
Aggregate Intrinsic Value exercisable $ 255    
Stock Options and Stock Appreciation Rights (SARs) | Exercise Price Range 63.04 To 74.77      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 5,220,662    
Weighted Average Remaining Contractual Life outstanding (in years) 7 years 5 months 1 day    
Weighted Average Exercise Price (in dollars per share) $ 74.23    
Aggregate Intrinsic Value outstanding $ 97    
Number of stock awards exercisable at end of the period (in shares) 1,368,924    
Weighted-Average Remaining Contractual Life exercisable (in years) 2 years 5 months 12 days    
Weighted Average Exercise Price (in dollars per share) $ 72.70    
Aggregate Intrinsic Value exercisable $ 27    
Stock Options and Stock Appreciation Rights (SARs) | Exercise Price Range 83.00 To 86.77      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 7,074,057    
Weighted Average Remaining Contractual Life outstanding (in years) 8 years 30 days    
Weighted Average Exercise Price (in dollars per share) $ 83.05    
Aggregate Intrinsic Value outstanding $ 69    
Number of stock awards exercisable at end of the period (in shares) 2,994,626    
Weighted-Average Remaining Contractual Life exercisable (in years) 8 years 2 months 6 days    
Weighted Average Exercise Price (in dollars per share) $ 83.00    
Aggregate Intrinsic Value exercisable $ 29    
Stock Options and Stock Appreciation Rights (SARs) | Exercise Price Range 88.51 To 96.31      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 8,576,789    
Weighted Average Remaining Contractual Life outstanding (in years) 6 years 5 months 25 days    
Weighted Average Exercise Price (in dollars per share) $ 92.88    
Aggregate Intrinsic Value outstanding $ 14    
Number of stock awards exercisable at end of the period (in shares) 5,434,984    
Weighted-Average Remaining Contractual Life exercisable (in years) 6 years 1 month 2 days    
Weighted Average Exercise Price (in dollars per share) $ 90.90    
Aggregate Intrinsic Value exercisable $ 14    
Stock Options and Stock Appreciation Rights (SARs) | Exercise Price Range 102.13 To 110.09      
Stock Options/SARs outstanding and exercisable      
Number of stock awards outstanding at end of the period (in shares) 5,787,742    
Weighted Average Remaining Contractual Life outstanding (in years) 4 years 8 months 15 days    
Weighted Average Exercise Price (in dollars per share) $ 106.31    
Aggregate Intrinsic Value outstanding $ 0    
Number of stock awards exercisable at end of the period (in shares) 5,787,742    
Weighted-Average Remaining Contractual Life exercisable (in years) 4 years 8 months 15 days    
Weighted Average Exercise Price (in dollars per share) $ 106.31    
Aggregate Intrinsic Value exercisable $ 0    
Restricted Stock Units (RSUs)      
Additional Stock-based Award Information under Restricted Stock Units Activity      
Weighted-average fair value per share of stock awards granted $ 68.04 $ 77.55 $ 89.18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 162 $ 109 $ 106
Outstanding at end of year (in shares) 3,071,014 4,330,513  
Weighted average remaining contractual life (in years) 1 year 2 months    
Performance Restricted Stock Units (PRSUs)      
Additional Stock-based Award Information under Restricted Stock Units Activity      
Weighted-average fair value per share of stock awards granted $ 64.71 $ 77.47 $ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 0 $ 0 $ 0
Outstanding at end of year (in shares) 710,286 132,068  
Weighted average remaining contractual life (in years) 1 year 9 months